A Cancer Test Has Investors Betting Big. But Will Insurers Pay? - WSJ

A Cancer Test Has Investors Betting Big. But Will Insurers Pay?  WSJGrail's cancer blood test nears landmark FDA approval, but insurance coverage looms  ReutersThis Stock, Up Almost 70%, May Have Found Cancer's Holy 'Grail'  Investor's Business DailyDogs sniffing for cancer  KTVU'A groundbreaking finding': Multi-cancer blood test could be available to the public next year  KGW